- Home
- ARCB vs PRCT Comparison
ARCB vs PRCT Comparison
Compare ARCB & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCB
- PRCT
- Stock Information
- Founded
- ARCB 1923
- PRCT 2009
- Country
- ARCB United States
- PRCT United States
- Employees
- ARCB N/A
- PRCT N/A
- Industry
- ARCB Trucking Freight/Courier Services
- PRCT Medical Specialities
- Sector
- ARCB Industrials
- PRCT Health Care
- Exchange
- ARCB Nasdaq
- PRCT Nasdaq
- Market Cap
- ARCB 1.7B
- PRCT 2.0B
- IPO Year
- ARCB N/A
- PRCT 2021
- Fundamental
- Price
- ARCB $64.90
- PRCT $31.39
- Analyst Decision
- ARCB Buy
- PRCT Strong Buy
- Analyst Count
- ARCB 11
- PRCT 8
- Target Price
- ARCB $91.64
- PRCT $59.00
- AVG Volume (30 Days)
- ARCB 310.7K
- PRCT 1.7M
- Earning Date
- ARCB 11-05-2025
- PRCT 11-04-2025
- Dividend Yield
- ARCB 0.75%
- PRCT N/A
- EPS Growth
- ARCB N/A
- PRCT N/A
- EPS
- ARCB 4.20
- PRCT N/A
- Revenue
- ARCB $4,039,115,000.00
- PRCT $299,907,000.00
- Revenue This Year
- ARCB N/A
- PRCT $48.38
- Revenue Next Year
- ARCB $4.85
- PRCT $30.87
- P/E Ratio
- ARCB $15.29
- PRCT N/A
- Revenue Growth
- ARCB N/A
- PRCT 50.07
- 52 Week Low
- ARCB $55.19
- PRCT $27.80
- 52 Week High
- ARCB $115.76
- PRCT $100.89
- Technical
- Relative Strength Index (RSI)
- ARCB 45.23
- PRCT 48.22
- Support Level
- ARCB $59.43
- PRCT $27.80
- Resistance Level
- ARCB $64.10
- PRCT $32.52
- Average True Range (ATR)
- ARCB 2.42
- PRCT 1.37
- MACD
- ARCB 0.07
- PRCT 0.29
- Stochastic Oscillator
- ARCB 60.87
- PRCT 70.54
About ARCB ArcBest Corporation
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.